Singapore

Singapore

Health Science Authority (HSA) Clinical Trial Register

Verified on September 9, 2021

Singapore has a clinical trial registry, HSA Clinical Trial Register. It is managed by the local health authority. It is not a World Health Organization (WHO) recognized primary registry. It has a provision for study registration with limited data set fields. There is no provision for results posting on HSA. The functionality of voluntarily posting the result will be available in the future.

Registries at a Glance
Registry PHUSE Categorization Information to be Entered By Route of Data in Registry Study Type Language
HSA Mandatory National Database (includes Ethics Requirement) Sponsor Through a dedicated registration platform (process independent from clinical trial application)

Interventional

(Phase 1-4)
English
Singapore Medical Device Register (SMDR) Mandatory National Database (includes Ethics Requirement) Sponsor Through a dedicated registration platform (process independent from clinical trial application)

Interventional

(Phase 1-4)
English
Registration and Results Requirements
Registry Activity Legal Requirement Timing
HSA Registration

Yes

Prior to enrollment
Results

n/a

Not applicable (NA)
SMDR Registration

Yes

Prior to enrollment
Results

n/a

NA

Registry Updates


References


  1. Additional details can be accessed through the following: Study with data fields. HSA. https://eservice.hsa.gov.sg/prism/ct_r/enquiry.do?action=getAllTherapeuticArea. Published September 1, 2012. Accessed November 12, 2018.
  2. Target Processing Timeline. HSA. https://www.hsa.gov.sg/clinical-trials/application/apply-cta-ctn. Accessed March 04, 2021